Will You Invest In Shark Tank's Namita Thapar's Company. Emcure Pharma IPO To Open On July 3rd

Подписаться 2,6 млн

Просмотров 10 тыс.

50% 1

#EmcurePharma #PharmaStocks #IPO #PrimaryMarket #NamitaThapar
Shark Tank's Namita Thapar is set to launch a ₹1,952 crore IPO for her pharma company, Emcure Pharmaceuticals. The IPO comprises a fresh issue of ₹800 crores and an offer for sale worth ₹1,152.03 crores. Opening for subscription from July 3 to July 5, 2024, the IPO price band is set between ₹960 and ₹1,008 per share, with a minimum application lot size of 14 shares, requiring a minimum investment of ₹14,112 for retail investors. Why is Emcure Pharma, established in 1981, aiming to list, and what are their strategic plans for FY25 and beyond? Join Business Today TV's Sakshi Batra as she interviews Emcure's Managing Director and CEO, Satish Mehta, along with Whole-time Director, Namita Thapar, to uncover insights and details about this significant IPO.
#EmcurePharmaIPO #NamitaThapar #SharkTankIndia #PharmaIPO #IPO2024 #StockMarket #InvestmentOpportunity #SatishMehta #PharmaIndustry #FinancialNews #IPOUpdate #InvestorAlert #PharmaStocks #MarketDebut #CapitalMarket #RetailInvestors #IPOListing #StrategicPlans
-----------------------
Thank You for watching! Do not forget to Like | Comment | Share
-----------------------
About the channel
Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others.
Follow us at:
Website: www.businesstoday.in
WhatsApp: whatsapp.com/channel/0029Va4Hd309hXFCqY62yD2I
Facebook: / businesstoday
twitter: / business_today
Instagram: / business_today

Опубликовано:

27 июн 2024

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 19

@brajeshsingh2391 5 дней назад

this is such a small company. And they are demanding a PE in excess of 100. Obviously they have tied the funding or else they would have not launched the IPO. But really these are ridiculous valuations when there are far better companies like Cipla, Dr. Reddy's who are available for cheaper valuations. She maybe director of Shark Tank where she asks entrepreneurs to make the pitch and get the judges to value the company but I cannot see how she can justify the valuations of her company

@princegdesai1971 4 дня назад

Pharma is going to grow but emcure might not be the one because of their declining profits

@user-wk7st5lm6k 2 дня назад

At a certain point, companies grow enough that they stop just saving their profits and start reinvesting them heavily. Some people mistake this reinvestment for a drop in profits. Namita Ji and Emcure Emcure has a valuable leader, Namita Ji. She is a significant asset to the company. On the show Shark Tank, Namita Ji has shown that she can make smart decisions, focusing on valuable opportunities without letting her ego or emotions affect her judgment.

@user-uq3ye8dq1g 2 дня назад

Quality of promoter is the most important in investing. Namita has clearly proved several times on the Shark Tank of her poor decision making skills! Clear No to investing in Emcure.

@GauravKumar-vr6nn 5 дней назад

Isme meri expertise nhi hai isliye I am out😂

@khodiyarnagar9925 4 дня назад

I am not from pune that's why I am out And also I'm not a women that's why I am out

@ketanvissawadia5936 2 дня назад

Need to avoid at such a expensive valuation....some might be thinking of listing gains but trust there are many other good options available in the market

@ajay1956in 3 дня назад

Issue proceeds not going to help in organic growth of company. Will give a pass to the issue which is attractive only because of Namita. 😊

@Iamreal11xingping 4 дня назад

Directorr

@KuldeepSingh-ue4sf 2 дня назад

Great company with very aggressive expansion plan available at very attractive IPO share price

@ketanvissawadia5936 2 дня назад

PROFITS DECLINING AND VALUATION SOARING .........NOT A GOOD IPO

@user-wk7st5lm6k 2 дня назад

@@ketanvissawadia5936 Businesses can legally pay taxes to bureaucrats or efficiently and aggressively re-invest and create more jobs. Reinvestment can not be confused with declining profits.

@mohitrohilla2301 5 дней назад

price band is very high so i am out this money waste ipo

@user-wk7st5lm6k 4 дня назад

201 patents granted, 33 applications pending! More resources in the able hands signify that everyone related to the investment will win, especially the patients. Congrats!

@KuldeepSingh-ue4sf 2 дня назад

Alreday trading at premium rate in grey market 👍

@ketanvissawadia5936 2 дня назад

you seem to be hired by the company....it does not take time for premium to come down